Lapisteride Explained

Lapisteride (INN; CS-891) is a dual inhibitor of both isoforms of the enzyme 5α-reductase.^[1] It was under investigation for the treatment of benign prostatic hyperplasia (BPH) and androgenic alopecia,^{[1] [2]} but was never marketed.

See also

• 5α-Reductase inhibitor

Notes and References

1. Niiyama S, Kojima K, Hamada T, Happle R, Hoffmann R . The novel drug CS-891 inhibits 5alpha-reductase activity in freshly isolated dermal papilla of human hair follicles . European Journal of Dermatology . 10 . 8 . 593–595 . December 2000 . 11125319 .
2. Book: Bernan . British Pharmacopoeia Commission . British Approved Names 2002 . 17 November 2011 . February 2002 . The Stationery Office . 978-0-11-322558-3 . 157 .